EUVIMEDEUVIMED entdecken
Crossref

Hyperbaric oxygen therapy for treatment of skull base Osteomyelitis

Johanna Gorenflo, Anne Lammert, Claudia Scherl, Haneen Sadick, Nicole Rotter

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S169

DOI: 10.1055/s-0044-1784535 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Johanna Gorenflo und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Skull base osteomyelitis is a rare, serious disease whose treatment remains a medical challenge. Positive effects of hyperbaric oxygen therapy in skull base osteomyelitis have been previously described. The case described shows a highly complicated course of disease with several conservative and surgical therapy attempts. Case An 80 year old male patient presented with an external ear infectionand house brackmann grade three facial paralysis. Intravenous therapy with piperacillin/tazobactam and prednisolone was carried out. Also first a paracentesis and tympanic drainage, then a mastoidectomy and facial nerve decompression were performed. Later the patient reported pain on the left temporal side, so an MRI and CT scan were performed, which revealed skull base osteomyelitis on the left with involvement of the petrous bone. Despite therapy with ceftriaxone, the patient developed a palsy of the left vagal, hypoglossal and glossopharyngeal nerve. We began hyperbaric oxygen therapy for one month with simultaneous administration of ceftazidime, clindamycin and caspofungin. This resulted in consistent imaging findings, but clinically complete resolution of the facial and glossopharyngeal nerve palsy, a reduction in the hypoglossal nerve palsy and persistence of the vagal nerve palsy. Therapy was continued with oral ciprofloxacin and fluconazole for 3 weeks. An MRI and neurological follow-up is planned after 3 months.

Conclusion

Accompanying hyperbaric oxygen therapy can improve the condition of treatment-resistant skull base osteomyelitis. Controlled studies on the use of hyperbaric oxygen therapy are required for final evaluation. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Gorenflo, J., Lammert, A., Scherl, C., Sadick, H., & Rotter, N. (2024). Hyperbaric oxygen therapy for treatment of skull base Osteomyelitis. Laryngo-Rhino-Otologie, 103(S 02 S 02), S169. https://doi.org/10.1055/s-0044-1784535

Vancouver

Gorenflo J, Lammert A, Scherl C, Sadick H, Rotter N. Hyperbaric oxygen therapy for treatment of skull base Osteomyelitis. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S169. doi:10.1055/s-0044-1784535

BibTeX
@article{Gorenflo2024,
  author = {Gorenflo, Johanna and Lammert, Anne and Scherl, Claudia and Sadick, Haneen and Rotter, Nicole},
  title = {Hyperbaric oxygen therapy for treatment of skull base Osteomyelitis},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S169},
  doi = {10.1055/s-0044-1784535}
}
Kostenlos starten →